DeGaming
DeGaming is an unverified brand name; the supplied evidence does not describe any entity by this name.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
No usable evidence was supplied for a commercial entity called DeGaming. The only source provided (E1) is a press release about Debiopharm, a privately owned Swiss biopharmaceutical company, and its MultiLINK antibody-drug-conjugate linker technology presented at World ADC San Diego 2026. That document contains no reference to DeGaming, to gaming, or to any related product, platform, or company. Because the name cannot be tied to a verifiable brand, company, product platform, retailer, or trademark, this entry is intentionally left minimal and flagged for review rather than filled with speculative details. If DeGaming is a gaming platform, esports organisation, or software brand, correct sourcing (official site, registry filing, or reputable press coverage) is required before a dossier can be written.
Recent events
- Unconfirmed
Reported
DeGaming partners with Lucky Coin[2]
DeGaming partnered with Lucky Coin to support the launch of Lucky Coin’s new cryptocurrency casino using DeGaming’s infrastructure and technology.
- Unconfirmed
Reported
DeGaming appoints Édi Varela as commercial director[3]
DeGaming, a Web3-native iGaming platform provider, has appointed Édi Varela as commercial director to drive strategic partnerships as the company enters its next phase of commercial growth following a recent rebrand. Varela joined from OpenTag, where he most recently served as head of sales.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/degaming · Editorial policy · How profiles are compiled